首页|瑞巴派特联合艾司奥美拉唑治疗胃溃疡的效果分析

瑞巴派特联合艾司奥美拉唑治疗胃溃疡的效果分析

扫码查看
目的 探讨瑞巴派特以及艾司奥美拉唑联用对胃溃疡患者的疗效.方法 回顾性选取2019年2月—2023年11月烟台业达医院收治的90例胃溃疡患者的临床资料,依据治疗方式不同分为两组,每组45例.对照组单用瑞巴派特,观察组在对照组的基础上联用艾司奥美拉唑.比较两组患者的胃肠激素水平和临床症状.结果 治疗后,两组患者的胃肠激素水平均明显改善,且观察组优于对照组,差异有统计学意义(P均<0.05).治疗后,观察组的腹胀、反酸、嗳气、烧心和胃部疼痛评分分别为(1.49±0.25)分、(1.63±0.28)分、(1.12±0.19)分、(1.27±0.26)分、(1.19±0.24)分,低于对照组的(2.27±0.36)分、(2.19±0.43)分、(1.63±0.28)分、(1.92±0.43)分、(1.83±0.42)分,差异有统计学意义(t=11.938、7.321、10.110、7.677、8.875,P均<0.05).结论 瑞巴派特以及艾司奥美拉唑联用对胃溃疡患者有显著的疗效.
Effect of Rebamipide Combined with Esomeprazole in the Treatment of Gastric Ulcer
Objective To investigate the efficacy of rebamipide and esomeprazole in the treatment of patients with gas-tric ulcer.Methods The clinical data of ninety patients with gastric ulcer admitted to Yantai Yeda Hospital from Feb-ruary 2019 to November 2023 were retrospectively selected and divided into two groups according to different treat-ment methods,with forty-five cases in each group.The control group received rebamipide alone,and the observation group combined with esomeprazole on the basis of control group.Gastrointestinal hormone levels and clinical symp-toms were compared between the two groups.Results After treatment,gastrointestinal hormone levels in both groups were significantly improved,and the observation group was better than that in the control group,the differences were statistically significant(all P<0.05).After treatment,the scores of abdominal distension,acid reflux,belching,heart-burn and stomach pain in the observation group were(1.49±0.25)points,(1.63±0.28)points,(1.12±0.19)points,(1.27±0.26)points and(1.19±0.24)points,respectively,lower than the control group(2.27±0.36)points,(2.19±0.4)points,(1.63±0.28)points,(1.92±0.43)points,(1.83±0.42)points,and the differences were statistically significant(t=11.938,7.321,10.110,7.677,8.875,all P<0.05).Conclusion The combination of Rebamipide and esomeprazole is effective in patients with gastric ulcer.

RebamipideEsomeprazoleGastric ulcer

王书阁、司君圣

展开 >

烟台业达医院消化内科,山东烟台 265500

瑞巴派特 艾司奥美拉唑 胃溃疡

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(16)
  • 19